Pluristem Therapeutics Inc.
Sub-category: Pharmaceuticals, Biopharmaceuticals, Biogenerics
Pluristem is a leading clinical-stage regenerative medicine company developing novel placenta-based cell therapy product, using a unique, proprietary, three-dimensional (3D) technology platform. These products are off-the-shelf, can be administered to patients without tissue matching to treat conditions such as inflammation, ischemia, muscle injuries, hematological disorders and radiation damages.
The highest quality cell products are manufactured in the companyâ€™s facility in Haifa, Israel.
Pluristem has a strong intellectual property position and strategic relationships with major research institutions.
|MATAM Park, Building 5, Haifa 31905, Israel|
To update your company data, click here.